Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$382,083
+$73,528 QoQ
Shares Held
2,438
+20.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,009
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebrook Private Inc. holds $12,172,247 across 9 Drug Manufacturers - General names. NVS ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,234 | $3,878,956 | |
| 2 | JNJ |
Johnson & Johnson
|
14,252 | $3,619,580 | |
| 3 | ABBV |
AbbVie Inc.
|
8,522 | $2,144,476 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,341 | $686,318 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,555 | $608,179 | |
| 6 | NVS |
Novartis AG
This page
|
2,438 | $382,083 | |
| 7 | AMGN |
Amgen Inc
|
848 | $307,077 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,201 | $278,074 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $382,083 | 2,438 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $308,555 | 2,020 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||